“Stem cells represent one of the most promising medical breakthroughs of all time”

“Currently, in 2009, the new US administration is lifting some major restrictions on stem cells technologies. This developmental obstacle now removed, all types of stem cells are available for expanding the therapeutic and commercial potentials…Based upon the cells that create and renew all tissues potentially, stem cell therapies could revolutionise the treatment of disease”

“A conservative estimate places the potential market value of stem cells at over $150bn by late next decade”

Source: Stem Cells – The Hype & Hope – World Analysis 2009-2024 - Pharmaceutical Report from Visiongain UK, March 2009

Executive Highlights
Get the Executive Highlights of GENova Biotherapeutics, Inc.
Strategic Partners
Biotech is a worldwide business – the best sourcing requires a global
team of talents.
Therapeutic Focus
GENova main targets: prostate
and breast cancer, not to mention
other solid tumours.
Investor Relations
See why you should invest in GENova Biotherapeutics, Inc.